Literature DB >> 18442633

Cardiovascular risk profile and morbidity in subjects affected by type 2 diabetes mellitus with and without diabetic foot.

Antonio Pinto1, Antonino Tuttolomondo, Domenico Di Raimondo, Paola Fernandez, Sergio La Placa, Maria Di Gati, Giuseppe Licata.   

Abstract

Diabetic foot syndrome (DFS) is the most frequent cause of hospitalization of diabetic patients and one of the most economically demanding complications of diabetes. People with diabetes have been shown to have higher mortality than people without diabetes. On this basis, the aim of our study was to evaluate the possible role of diabetic foot as a cardiovascular risk marker in patients with type 2 diabetes mellitus. We enrolled 102 consecutive patients with type 2 diabetes mellitus with diabetic foot and 123 patients with type 2 diabetes mellitus without limb lesions to compare the prevalence of main cardiovascular risk factors, subclinical cardiovascular disease, previous cardiovascular morbidity, and incidence of new vascular events on a 5-year follow-up. Diabetic patients with diabetic foot were more likely to have a higher prevalence of cardiovascular risk factors such as hypercholesterolemia, hypertriglyceridemia, hyperuricemia, and microalbuminuria or proteinuria, a higher prevalence of a previous cardiovascular morbidity (coronary artery disease, transient ischemic attack/ischemic stroke, diabetic retinopathy), and a higher prevalence of subclinical cardiovascular disease. Furthermore, diabetic patients with foot ulceration showed, on a 5-year follow-up, a higher incidence of new-onset vascular events (coronary artery disease, transient ischemic attack/ischemic stroke, diabetic retinopathy). At multivariate analysis, duration of diabetes, age, hemoglobin A1c, and DFS maintained a significant association with cardiovascular morbidity; but DFS presence showed the highest hazard ratio.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442633     DOI: 10.1016/j.metabol.2008.01.004

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  23 in total

1.  The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration.

Authors:  Suzan Tabur; Mehmet Ali Eren; Yakup Çelik; Omer Faruk Dağ; Tevfik Sabuncu; Zeynel Abidin Sayiner; Esen Savas
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

Review 2.  Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes.

Authors:  Antonino Tuttolomondo; Carlo Maida; Antonio Pinto
Journal:  World J Orthop       Date:  2015-01-18

3.  Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.

Authors:  Caitlin W Hicks; Dan Wang; Kunihiro Matsushita; B Gwen Windham; Elizabeth Selvin
Journal:  Ann Intern Med       Date:  2020-12-08       Impact factor: 25.391

4.  The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis.

Authors:  J R W Brownrigg; J Davey; P J Holt; W A Davis; M M Thompson; K K Ray; R J Hinchliffe
Journal:  Diabetologia       Date:  2012-08-14       Impact factor: 10.122

Review 5.  Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes.

Authors:  Caitlin W Hicks; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2019-08-27       Impact factor: 4.810

Review 6.  Serum Uric Acid Levels and Diabetic Peripheral Neuropathy in Type 2 Diabetes: a Systematic Review and Meta-analysis.

Authors:  Shuai Yu; Ying Chen; Xu Hou; Donghua Xu; Kui Che; Changgui Li; Shengli Yan; Yangang Wang; Bin Wang
Journal:  Mol Neurobiol       Date:  2015-01-12       Impact factor: 5.590

Review 7.  The impact of foot ulceration and amputation on mortality in diabetic patients. I: From ulceration to death, a systematic review.

Authors:  Daniel C Jupiter; Jakob C Thorud; Clifford J Buckley; Naohiro Shibuya
Journal:  Int Wound J       Date:  2015-01-20       Impact factor: 3.315

8.  Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity.

Authors:  Antonino Tuttolomondo; Sergio La Placa; Domenico Di Raimondo; Chiara Bellia; Antonietta Caruso; Bruna Lo Sasso; Giovanni Guercio; Giuseppe Diana; Marcello Ciaccio; Giuseppe Licata; Antonio Pinto
Journal:  Cardiovasc Diabetol       Date:  2010-09-13       Impact factor: 9.951

9.  Impaired T-cell differentiation in diabetic foot ulceration.

Authors:  João Moura; João Rodrigues; Marta Gonçalves; Cláudia Amaral; Margarida Lima; Eugénia Carvalho
Journal:  Cell Mol Immunol       Date:  2016-03-21       Impact factor: 11.530

10.  Comorbidity and glycemia control among patients with type 2 diabetes in primary care.

Authors:  Catherine Hudon; Martin Fortin; Marie-France Dubois; José Almirall
Journal:  Diabetes Metab Syndr Obes       Date:  2008-11-18       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.